Epion Therapeutics

EyeYon

This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.

Trefoil Therapeutics

The company develops engineered protein therapies to treat corneal endothelial and epithelial diseases for patients with vision loss or ocular surface damage.

Amber Ophthalmics

The company develops biopharmaceutical therapies to treat rare anterior segment eye diseases such as persistent corneal epithelial defects for patients.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Optherion

The company develops diagnostic tools and therapeutics for age-related macular degeneration and rare renal diseases for patients and healthcare providers.

Kedalion Therapeutics

This company develops electromechanical ocular delivery devices for patients with eye conditions requiring precise topical medication administration.

Healome Therapeutics

The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.

Cornea Project

This company develops point-of-care diagnostic devices and molecular biomarker analysis technologies for ophthalmologists to detect corneal diseases like keratoconus and dry eye syndrome.